Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FNM8H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,394
Award facts
- Contract value 100% obligated
- $47,394.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Cosentyx (secukinumab) 300 mg pens in 2 mL configurations, valued at $47,394.16. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of November 19, 2025. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, providing a comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The company's federal contract awards demonstrate consistent capability to fulfill competitive procurements across multiple therapeutic domains and delivery requirements. The supply of Cosentyx, an immunosuppressive biologic used for autoimmune conditions, reflects the company's role in supporting the medical needs of the Department of Defense healthcare system through the DLA's medical supply procurement operations.
Quick answers
Who was awarded contract SPE2DR26FNM8H?
SPE2DR26FNM8H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FNM8H worth?
The government has obligated $47,394 on SPE2DR26FNM8H.
Is contract SPE2DR26FNM8H an order under another contract?
Yes. SPE2DR26FNM8H is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNM8H competed?
The extent of competition for SPE2DR26FNM8H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award